Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 29.81%
March 31, 2026 29.78%
December 31, 2025 28.92%
September 30, 2025 28.69%
June 30, 2025 29.38%
March 31, 2025 29.61%
December 31, 2024 29.14%
September 30, 2024 29.27%
June 30, 2024 30.45%
March 31, 2024 29.98%
December 31, 2023 28.74%
September 30, 2023 29.60%
June 30, 2023 29.87%
March 31, 2023 30.13%
December 31, 2022 28.30%
September 30, 2022 28.33%
June 30, 2022 29.70%
March 31, 2022 29.13%
December 31, 2021 29.41%
September 30, 2021 28.70%
June 30, 2021 29.99%
March 31, 2021 30.46%
December 31, 2020 27.16%
September 30, 2020 26.56%
June 30, 2020 26.97%
Date Value
March 31, 2020 30.72%
December 31, 2019 30.37%
September 30, 2019 30.34%
June 30, 2019 31.35%
March 31, 2019 31.85%
December 31, 2018 30.37%
September 30, 2018 30.67%
June 30, 2018 31.02%
March 31, 2018 31.63%
December 31, 2017 27.15%
September 30, 2017 26.45%
June 30, 2017 27.43%
March 31, 2017 28.15%
December 31, 2016 27.62%
September 30, 2016 27.56%
June 30, 2016 27.96%
March 31, 2016 28.73%
December 31, 2015 28.04%
September 30, 2015 27.88%
June 30, 2015 28.55%
March 31, 2015 28.96%
December 31, 2014 28.29%
September 30, 2014 27.51%
June 30, 2014 27.85%
March 31, 2014 28.67%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Cencora, Inc. 3.93%
Accendra Health, Inc. 37.62%
Fuse Medical, Inc. --
Cardinal Health, Inc. 3.87%
McKesson Corp. 3.31%